glp-1 news insurers Insurance companies scrambling to support need for drugs - Insurance Some insurers are dropping GLP-1

Meanwhile, the Trump administration has included the GLP-1 drugs Ozempic, Wegovy, and Rybelsus on its list of 15 medicines that will be subject to price negotiations with pharmaceutical manufacturers under its Medicare Part D program, a system created during the Biden administration amid opposition from Republicans

Semaglutide is a peptide that belongs to a class of medications known as glucagon-like peptide-1 receptor agonists or better known as GLP-1 RAs

Body mass index alone does not predict eating disorder risk and using it as the primary metric for GLP-1 candidacy misses a significant proportion of people who need a more careful evaluation

Compounding pharmacies may encourage prescribers to document minor or theoretically beneficial changessuch as adding a vitamin (e.g., B12 or L-Carnitine) to a GLP-1 injectionto assert that the compounded product is not a copy of the commercial drug

CivicScience data indicate people who use Ozempic or other GLP-1 medications consistently report changes in common behaviors, including meals and snack consumption, grocery shopping, dining out, exercising, and more

[DOI] [PubMed] [Google Scholar] 29.Engin A